Our Mission

Addressing global healthcare challenges with every patient in mind

In collaboration with our partners, our passion is to identify the challenges within our clinical community while offering solutions that provide a positive impact for the physicians and patients.

Celebrating 25 Years of Mentice!

What we do

Market-leading simulation and performance-enhancing solutions

As the global population ages, with the expectation to stay healthy and active as we age, availability of treatment options is increasing rapidly for treatment of non-communicable diseases, such as cardiovascular diseases. By utilizing our solutions, healthcare providers and the medtech industry can effectively acquire, maintain and share skills for new and innovative interventional techniques and therapies, while also making sure that each intervention is performed in the best way possible. 

Physicians can learn a variety of skills from technical skills acquisition, device and patient selection processes, step by step procedural planning, workflow management, all the way through to performing simulated procedures in the operating room.  

Ultimately, the company’s solutions are used by physicians to support their mission to save lives. Mentice solutions support the intended reduction of pain and time in the hospital by allowing more patients to get the best minimally invasive care available.

The Company

For 25 years our solutions and collaborations have helped the advancement of non-invasive and innovative life-changing treatments.

Launched in 1999, Mentice is the leading provider of software and hardware simulation solutions for image guided interventional therapies.
‍
Our solutions are scientifically validated and have been specifically developed for health care providers and the medical device industry. For more than 25 years, we have partnered with all the top manufacturers and their world-renowned key opinion leaders to develop image guided interventional  simulation solutions that use real and or virtual medical devices and provide real-life haptic feedback.

In 2020 Mentice acquired Vascular Simulations in order to enhance our product line by offering solutions supporting medical device development from concept to market-rollout.

In 2022, Mentice acquired Ankyras - a CE &FDA cleared clinical decision support application designed to assist Interventional Neuroradiologists in selecting the most suitable flow diverter before interventional treatment of intracranial aneurysms. Ankyras offers an intuitive and precise solution for clinical treatment planning, leading to more accurate prediction than traditional methods.

700

clients and an increasing number of the world's leading physicians

3100+

systems delivered to the market

117

employees and operators in 9 countries

25

years of proven and powerful technology base developement